Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1707-1719, July 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Seibert, K.
Right arrow Articles by Nordin, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Seibert, K.
Right arrow Articles by Nordin, A.

Some Aspects of Humoral Immunity in Germ-free and Conventional SJL/J Mice in Relation to Age and Pathology1

Katherine Seibert2, Morris Pollard3 and Albert Nordin

Creighton University School of Medicine, Omaha, Nebraska 68178 [K. S.]; Lobund Laboratory, University of Notre Dame, Notre Dame, Indiana 46556 [M. P.]; and National Institute of Child Health and Human Development, Gerontology Research Center, Baltimore City Hospitals, Baltimore, Maryland 21224 [A. N.]

In this study the humoral immune competence of 130 germ-free and 137 conventional SJL/J mice was evaluated with increasing age. This evaluation was accomplished by means of the hemolytic plaque assay, in which spleen cells from 2- to 14-month-old animals were used to determine the presence of specific IgM and {gamma}1 antibody-forming cells on Days 4, 5, and 6 after i.p. immunization with sheep erythrocytes. All animals were autopsied; spleen weights and total and differential peripheral blood leukocyte counts were recorded, and selected tissues were processed for histological study by light microscopy. Total protein estimates and {gamma}-globulin comparisons, by means of acrylamide gel electrophoresis, were made on serum samples from selected animal groups.

The results show a similar plaque response between germ-free and conventional animals at all levels, as reflected in their ability to form specific antibody against sheep erythrocytes. The peak response for both IgM and {gamma}1 production occurred at age 4 months with a subsequent progressive, marked, age-related decline. However, the age-associated depression was not consistent; most of the 10- to 14-month-old animals showed a severely depressed response, but a few aged animals responded at a level comparable to that of the 4-month-old group. The {gamma}1 response was more severely impaired with age than the IgM response; however, the latter response showed a delay of 1 day in the peak of the response with aging. Animals with the lowest plaque-forming cell responses had high spleen weights and the most severe histological lesions of any of the groups studied. Animals with lymphoreticular lesions characterized by a predominance of reticulum cells, by a depletion of small lymphocytes and plasma cells, and by the presence of significant areas of fibrosis and cellular depletion had low or negative plaque-forming cell responses and low levels of {gamma}-globulin. Animals with plasmacytic or lymphocytic hyperplasia had consistently high globulin levels but an unpredictable plaque-forming cell response. The peripheral blood total leukocyte and lymphocyte counts decreased significantly with age and progress of the disease.

These results found in the germ-free and in conventional SJL/J mice indicate that these animals have humoral immune dysfunction both as a predisposition and as a sequela to their characteristic lymphoreticular neoplasia.

1 This work was supported in part by NIH Grant RR002924 and Sigma Delta Epsilon Grant-in-Aid.

2 This work is based on a dissertation submitted in partial fulfillment of the requirements for the Ph.D. degree at the University of Notre Dame.

3 To whom reprint requests should be addressed, at Lobund Laboratory, University of Notre Dame, Notre Dame, Ind. 46556.

Received 7/20/73. Accepted 4/ 8/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.